ARCHIVES

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination

October 3, 1986

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

March 3, 2006

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

NCI Cooperative Group Clinical Trials Approved

August 27, 2010